News

Find out about the latest developments in our dynamic translational research

Bowel cancer patients going undiagnosed due to COVID distruption

A new study led by the University of Oxford has found that since the first coronavirus lockdown the number of people diagnosed with bowel cancer in England has fallen sharply, with a deficit persisting up to October 2020
Prof Ahmed Ahmed in his lab

“The Oxford Classic” classification system uncovers new information about ovarian cancers

Oxford cancer researchers have developed a new way of subtyping ovarian cancer that enables the accurate prediction of patient outcome and sheds light onto the role the immune system plays in ovarian cancer response to treatment.

Oxford spin out financed $6.8m for research into oncolytic therapies

Oxford spin out company Theolytics has closed a $6.8m deal to support their work into developing novel cancer therapies from viruses

Being a part of cancer drug discoveries

Susan Cakebread, gives her account of being on an experimental drug trial here in Oxford
National Foundation for Cancer Research

Investigating the effects of co-morbidities on liver cancer risk

Dr Philippa Matthews and colleagues review the associations between liver cancer risk and co-morbidities and other metabolic factors in individuals with chronic hepatitis B virus infection.

Potential of DNA-based blood tests for detecting pancreatic cancer earlier

Dr Shivan Sivakumar and colleagues evaluate the current progress and future potential in using genetic and epigenetic methods for detecting pancreatic cancer DNA in the blood

Bioengineering the human gut

An interdisciplinary collaboration generates an advanced model of the human gastrointestinal tract with broad applications for disease research and regenerative medicine

Pancreatic Cancer Awareness Month

A round up of Pancreatic Cancer Awareness Month at the University of Oxford

SCALOP team discover new pancreatic cancer biomarker

The SCALOP clinical trial team have uncovered a new therapeutic target for locally advanced pancreatic cancer. Read more about it and the next steps for the SCALOP-2 trial.
Image from an endoscopy video with the detected artefacts highlighted with coloured boxes.

Using AI to improve the quality of endoscopy videos

A multidisciplinary team of researchers has developed a deep-learning framework for improving endoscopy to aid cancer detection.

New melanoma drug a step closer to the clinic

Clinical trials into the use of Tebentafusp for metastatic uveal melanoma have been conducted by the University of Oxford and Immunocore. The positive results of the most recent trial mean this drug could now be used in future treatment.

The search for pancreatic cancer biomarkers

Nuffield Department of Population Health researchers are using the China Kadoorie Biobank to identify potential protein biomarkers in the blood that could be used to predict the presence or development of pancreatic cancer